Cancer Detection and Diagnosis Research in Florida
Cancer Detection and Diagnosis Research (93.394) awarded $48.0 million to recipients in Florida in 38 grants from fiscal 2021 to 2025, 1.8% of the program's national total. H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received the most, $16.9 million.
- Awarded in Florida$48.0 million
- Awards38
- Share of the program1.8%
- Rank among states16th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 18 | $9.0 million |
| FY 2022 | 20 | $8.4 million |
| FY 2023 | 19 | $7.5 million |
| FY 2024 | 19 | $10.0 million |
| FY 2025 | 20 | $13.1 million |
Recipients in Florida
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. | Nonprofits | 13 | $16.9 million |
| University of Florida | Colleges and universities | 7 | $11.4 million |
| University of Miami | Colleges and universities | 8 | $9.1 million |
| Mayo Clinic Jacksonville (a Nonprofit Corporation) | Nonprofits | 6 | $5.5 million |
| University of South Florida | Colleges and universities | 2 | $3.2 million |
| Vigilant Laboratories LLC | Small businesses | 1 | $1.0 million |
| Florida International University | Colleges and universities | 1 | $816,811 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Florida?
$48.0 million from fiscal 2021 to 2025, across 38 awards. Florida ranks 16th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Florida?
The largest recipient is H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., with $16.9 million in 13 awards. Next are University of Florida and University of Miami.
Can organizations in Florida apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Florida
- Grants to States for Medicaid
- Education Stabilization Fund
- Highway Planning and Construction
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Special Education Grants to States
- Children's Health Insurance Program